Robust validation is the foundation of reliable flow cytometry biomarker analysis.

Generating consistent flow cytometry data for clinical trials requires well-designed validation studies and standardized analytical approaches. This poster highlights the validation of flow cytometry assays used to characterize immune cell populations, with a focus on assay performance, sample handling, event acquisition, and reproducibility to support reliable biomarker assessments.

Key highlights include:

• Validation of flow cytometry assays for immune cell characterization
• Evaluation of assay precision and reproducibility
• Best practices for sample handling and event acquisition
• Considerations for generating consistent biomarker data across clinical studies
• Strategies for supporting robust flow cytometry assays in regulated environments

As flow cytometry continues to play a growing role in biomarker research, robust validation practices are essential for producing reliable, reproducible data. Learn how standardized approaches can help support high-quality biomarker assessments throughout clinical development.